EGFR Resisters Research Summit(@EGFRSummit) 's Twitter Profileg
EGFR Resisters Research Summit

@EGFRSummit

Summit: Nov 2-4, 2023 • Chicago, IL • @egfrresisters @CEC_onc
Abstract Submission Deadline: CLOSED⏩https://t.co/i1jrgLUVG3

ID:1146064602888855553

calendar_today02-07-2019 14:34:28

720 Tweets

1,1K Followers

151 Following

Dr. Luis E. Raez(@LuisRaezMD) 's Twitter Profile Photo

The U.S. FDA has granted breakthrough therapy designation to sunvozertinib (DZD9008) from Dizal Pharmaceutical as frontline treatment for patients with metastatic NSCLC whose disease harbors an EGFR exon 20 insertion mutation! more options for our EGFR Resisters patients EGFR Resisters Research Summit

account_circle
EGFR Resisters(@EGFRResisters) 's Twitter Profile Photo

New Webinar EGFR Resisters 'Ask the Experts' Clinical Trials w/ Uncommon EGFR Alterations in NSCLC w/ Drs Halmos Balazs Halmos & Julia Rotow MD
Access here: ceconcepts.com/egfr-resisters…
This was possible w/ a grant from Black Diamond Therapeutics & created with the help of CEC Oncology

account_circle